首页 | 本学科首页   官方微博 | 高级检索  
     

生长抑素联合空肠营养管在新生儿先天性肠闭锁术后的应用效果观察
引用本文:白剑,梁劲文,李秋菊,王少梅,梁裕柱,吴敏秋. 生长抑素联合空肠营养管在新生儿先天性肠闭锁术后的应用效果观察[J]. 岭南现代临床外科, 2018, 18(4): 393-396. DOI: 10.3969/j.issn.1009?976X.2018.04.006
作者姓名:白剑  梁劲文  李秋菊  王少梅  梁裕柱  吴敏秋
作者单位:佛山市南海区妇幼保健院小儿外科
摘    要:目的观察生长抑素联合空肠营养管在新生儿先天性肠闭锁术后的应用效果。方法选择行先天性肠闭锁术新生儿50例,根据不同术后营养治疗方法分为对照组和观察组,每组25例。对照组给予单一生长抑素治疗,观察组给予生长抑素联合空肠营养管治疗,对比两组患儿的手术方式、术后住院时间、体质量变化、不良反应发生情况等。结果两组患者的手术方式比较无明显统计学差异(P0.05);与对照组比较,观察组患者的住院时间明显缩短,3、7、14d的体质量明显增长,差异具有统计学意义(P0.05)。观察组不良反应发生率4.0%(1/25)明显低于对照组32.0%(8/25)(P0.05)。观察组隐血试验转阴时间、血红蛋白下降等情况都显著优于对照组(P0.05)。结论生长抑素联合空肠营养管应用于新生儿先天性肠闭锁术后患儿中,能够改善患儿的营养状态,降低不良反应发生率,具有较高的应用价值。

关 键 词:生长抑素  空肠营养管  新生儿先天性肠闭锁术后  

The research on effect of somatostatin combined with jejunal nutrition tube on neonatal congenital intestinal atresia
BAI Jian,LIANG Jingwen,LI Qiuju,WANG Shaomei,LIANG Yuzhu,WU Minqiu. The research on effect of somatostatin combined with jejunal nutrition tube on neonatal congenital intestinal atresia[J]. Lingnan Modern Clinics in Surgery, 2018, 18(4): 393-396. DOI: 10.3969/j.issn.1009?976X.2018.04.006
Authors:BAI Jian  LIANG Jingwen  LI Qiuju  WANG Shaomei  LIANG Yuzhu  WU Minqiu
Affiliation:Department of Pediatric Surgery,Women s and Children s Health Care Institute of Nanhai District, Foshan,Guangdong 512236,China
Abstract:[Abstract] Objective To observe the effect of somatostatin combined with jejunal nutrition tube onneonatal congenital intestinal atresia. Methods Fifty neonates with congenital intestinal atresia were divided into control group and observation group by different treatment method. The control group was treated with single somatostatin,the observation group was treated with somatostatin combined with jejunal nutrition tube,and the changes of body mass and adverse reactions were compared between the two groups. Results There was no significant difference in surgical methods between the two groups (P> 0.05). Compared with the control group,the length of hospitalization in the observation group was significantly shorter than that in the control group(P<0.05). After 3,7 and 14 days of treatment,the increase of body mass in the observation group was significantly greater than that in the control group(P< 0.05). The incidence of adverse reactions was 4.0%(1/25)in the observation group and 32.0%(8/25)in the control group(P<0.05). The occult blood test of the observation group was significantly better than that of the control group (P<0.05). Conclusion Somatostatin combined jejunum nutrition tube used in postoperative children with neonatal congenital intestinal atresia,it can improve the nutritional status of children,reduce the incidence of adverse reactions,has higher application value.
Keywords:somatostatin  jejunal nutrition tube  neonatal congenital intestinal atresia  
本文献已被 CNKI 等数据库收录!
点击此处可从《岭南现代临床外科》浏览原始摘要信息
点击此处可从《岭南现代临床外科》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号